Deerfield Partners, L.P., 10% Owner at SALIX PHARMACEUTICALS LTD (SLXP), sold 357,612 shares at $13.11 ($4.6M) on 2009-07-27, disclosed to the SEC on 2009-07-29.
Open-market sale of $4.6M SLXP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.11 | 57,689 | $756K | 16.3% |
| 2 | $13.11 | 86,540 | $1.1M | 24.4% |
| 3 | $12.98 | 75,448 | $979K | 21.1% |
| 4 | $12.98 | 113,182 | $1.5M | 31.6% |
| 5 | $12.55 | 9,901 | $124K | 2.7% |
| 6 | $12.55 | 14,852 |
| $186K |
| 4.0% |
| Total | $13.00 avg | 357,612 | $4.6M | 100% |
| Filing → |
| ATRS | SELL | 2015-06-23 | $1.2M | — | Filing → |
| ASPX | BUY | 2015-01-28 | $84.8M | — | Filing → |
| RIGL | BUY | 2011-06-07 | $5.2M | — | Filing → |